Allogeneic bone marrow transplantation for children with acute myelocytic leukemia in first remission demonstrates a role for graft versus leukemia in the maintenance of disease-free survival

Blood

Volumn 103, Issue 10, 2004, Pages 3655-3661

  Neudorf, Steven ^a   Sanders, Jean ^b   Kobrinsky, Nathan ^b   Alonzo, Todd A ^b   Buxton, Allen B ^b   Gold, Stuart ^b   Barnard, Dorothy R ^b   Wallace, Joetta D ^b   Kalousek, Dagmar ^b   Lange, Beverly J ^b   Woods, William G ^b  

^a CHILDREN S ONCOLOGY GROUP   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; BUSULFAN; CLOTRIMAZOLE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; HLA ANTIGEN; METHOTREXATE; NYSTATIN; TIOGUANINE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; FEMALE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEPATOMEGALY; HIGH RISK PATIENT; HUMAN; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROPHYLAXIS;

EID: 2342561730     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-08-2705     Document Type: Article

References (26)

1. Woods WG, Kobrinsky N, Buckley JD, et al. Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer Group. Blood. 1996;87:4979-4989.
2. Woods WG, Neudorf S, Gold S, et al. A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission. Blood. 2001;97: 56-62.
3. Sanders JE, Thomas ED, Buckner, CD, et al. Marrow transplantation for children in first remission of acute non-lymphoblastic leukemia: an update. Blood. 1985;66:460-462.
4. Nesbit ME, Buckley JD, Feig SA, et al. Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: a report from the Children's Cancer Group. J Clin Oncol. 1994;12:127-135.
5. Dahl GV, Kalwinsky DK, Mirro J, et al. Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission. J Clin Oncol. 1990;8:295-303.
6. Ravindranath Y, Yeager AM, Chang MN, et al. Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. N Engl J Med. 1996;334:1428-1434.
7. Amadori S, Testi AM, Arico M, et al. Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. J Clin Oncol. 1993;11:1046-1054.
8. Brochstein JA, Keman NA, Groshen S, et al. Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia. N Engl J Med. 1987;317:1618-1624.
9. Ferrant A, Labopin M, Frassoni F, et al. Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Blood. 1997;90:2931-2938.
10. Michallet M, Vernant T, Kuentz M, et al. Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Societe Francaise de Greffe de Moelle (SFGM). Bone Marrow Transplant. 2000;26:1157-1163.
11. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation. 1974;18:295-304.
12. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:475-481.
13. Greenwood M. The natural duration of cancer. In: Reports on Public Health and Medical Subjects. London, England: His majesty's stationary office; 1926;33:1-26.
14. Peto R, Peto J. Asymptomatically efficient rank invariant test procedures. J R Stat Soc. 1972; 135:185-206.
15. Cox DR. Regression models and life-tables. J R Stat Soc. 1972;34:187-220.
16. Feig SA, Lampkin B, Nesbit ME, et al. Outcome of BMT during first complete remission of AML: a comparison of two sequential studies by the Children's Cancer Group. Bone Marrow Transplant. 1993;12:65-71.
17. Weaver CH, Clift RA, Deeg HJ, et al. Effect of graft-versus-host disease prophylaxis on relapse in patients transplanted for acute mysloid leukemia. Bone Marrow Transplant. 1994;14:885-893.
18. Jernberg A, Remberger M, Ringden O, Winiarski J. Graft versus leukemia effect in children: chronic GVHD has a significant impact on relapse and survival. Bone Marrow Transplant 2003;31: 175-181.
19. Nash R, Pepe M, Storb R, et al. Acute graft versus host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood 1992; 80:1838-1845.
20. Weisdorf D, Hakke R, Blazar B, et al. Risk factors for acute graft versus host disease in histocompatible donor bone marrow transplantation. Transplantation. 1991;51:1197-1203.
21. Ramsay N, Kersey J, Robison L, et al. A randomized study of the prevention of acute graft versus host disease. N Engl J Med. 1982;306:392-397.
22. Bross D, Tutschka P, Farmer E, et al. Predictive factors for acute graft versus host disease in patients transplanted with HLA identical bone marrow. Blood. 1984;63:1265-1270.
23. Beatty P, Clift R, Mickelson E, et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med. 1985;313:765-771.
24. Neudorf S, Sanders J, Howells WN, et al. The beneficial role of autologous bone marrow transplantation in the treatment of childhood acute myeloid leukemia: a report from the Children's Cancer Group [abstract]. Blood. 1998;92:1204a.
25. Hassan M, Ljungman P, Bolme P, et al. Busulfan bioavailability. Blood. 1994;84:2144-2150.
26. Vassal G, Fische A, Challine D, et al. Busulfan disposition below the age of three: alteration in children with lysosomal storage disease. Blood. 1993;82:1030-1034.